Switch theme
Sign up to access all valuation multiples
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.
2008
37.0K+
LTM Revenue $16.2B
LTM EBITDA $3.7B
$25.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Otsuka Holdings has a last 12-month revenue (LTM) of $16.2B and a last 12-month EBITDA of $3.7B.
In the most recent fiscal year, Otsuka Holdings achieved revenue of $16.0B and an EBITDA of $3.1B.
Otsuka Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Otsuka Holdings valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $16.2B | XXX | $16.0B | XXX | XXX | XXX |
| Gross Profit | $11.6B | XXX | $11.5B | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $3.7B | XXX | $3.1B | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $2.4B | XXX | $2.9B | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $2.2B | XXX | $2.4B | XXX | XXX | XXX |
| Net Margin | 14% | XXX | 15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Otsuka Holdings's stock price is JPY 7350 (or $50).
Otsuka Holdings has current market cap of JPY 3.88T (or $26.6B), and EV of JPY 3.70T (or $25.4B).
See Otsuka Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25.4B | $26.6B | XXX | XXX | XXX | XXX | $4.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Otsuka Holdings has market cap of $26.6B and EV of $25.4B.
Otsuka Holdings's trades at 1.6x EV/Revenue multiple, and 8.2x EV/EBITDA.
Equity research analysts estimate Otsuka Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Otsuka Holdings has a P/E ratio of 12.0x.
See valuation multiples for Otsuka Holdings and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $26.6B | XXX | $26.6B | XXX | XXX | XXX |
| EV (current) | $25.4B | XXX | $25.4B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 6.9x | XXX | 8.2x | XXX | XXX | XXX |
| EV/EBIT | 10.5x | XXX | 8.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 12.0x | XXX | 11.3x | XXX | XXX | XXX |
| EV/FCF | 23.6x | XXX | 16.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOtsuka Holdings's last 12 month revenue growth is 2%
Otsuka Holdings's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Otsuka Holdings's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Otsuka Holdings's rule of X is 29% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Otsuka Holdings and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | -5% | XXX | 45% | XXX | XXX | XXX |
| Rule of 40 | 15% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Otsuka Holdings acquired XXX companies to date.
Last acquisition by Otsuka Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Otsuka Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Otsuka Holdings founded? | Otsuka Holdings was founded in 2008. |
| Where is Otsuka Holdings headquartered? | Otsuka Holdings is headquartered in Japan. |
| How many employees does Otsuka Holdings have? | As of today, Otsuka Holdings has 37.0K+ employees. |
| Who is the CEO of Otsuka Holdings? | Otsuka Holdings's CEO is Mr. Makoto Inoue. |
| Is Otsuka Holdings publicy listed? | Yes, Otsuka Holdings is a public company listed on TKS. |
| What is the stock symbol of Otsuka Holdings? | Otsuka Holdings trades under 4578 ticker. |
| When did Otsuka Holdings go public? | Otsuka Holdings went public in 2010. |
| Who are competitors of Otsuka Holdings? | Similar companies to Otsuka Holdings include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Otsuka Holdings? | Otsuka Holdings's current market cap is $26.6B |
| What is the current revenue of Otsuka Holdings? | Otsuka Holdings's last 12 months revenue is $16.2B. |
| What is the current revenue growth of Otsuka Holdings? | Otsuka Holdings revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Otsuka Holdings? | Current revenue multiple of Otsuka Holdings is 1.6x. |
| Is Otsuka Holdings profitable? | Yes, Otsuka Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Otsuka Holdings? | Otsuka Holdings's last 12 months EBITDA is $3.7B. |
| What is Otsuka Holdings's EBITDA margin? | Otsuka Holdings's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Otsuka Holdings? | Current EBITDA multiple of Otsuka Holdings is 6.9x. |
| What is the current FCF of Otsuka Holdings? | Otsuka Holdings's last 12 months FCF is $1.1B. |
| What is Otsuka Holdings's FCF margin? | Otsuka Holdings's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Otsuka Holdings? | Current FCF multiple of Otsuka Holdings is 23.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
